Skip to content

Inspiratory Muscle Training in Hypercapnic COPD

Randomized Controlled Trial of Inspiratory Muscle Training in Patients With Stable Hypercapnic Respiratory Failure Due to COPD

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00291460
Enrollment
40
Registered
2006-02-14
Start date
2006-02-28
Completion date
2008-03-31
Last updated
2006-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Respiratory Failure

Keywords

COPD, respiratory failure, inspiratory muscle training

Brief summary

The trial intends to investigate, whether inspiratory muscle training in hypercapnic patients improves inspiratory muscle strength, inspiratory muscle endurance and endurance to walk within six minutes.

Detailed description

Inspiratory muscle training is known to improve inspiratory muscle strength, inspiratory muscle endurance and walking distance within six minutes in patients with neuromuscular and thoraco-restrictive disease as well as in patients with COPD. Studies have only been conducted in patients without established respiratory failure. COPD patients with respiratory failure though are characterized by higher work rates of the inspiratory muscles and higher esophageal pressure swings compared to non-hypercapnic patients indication a discrepancy between muscle load and muscle capabilities. Therefore we hypothesize that for these patients training of their inspiratory muscles will be of benefit in terms of improvement of muscular and whole body endurance. During this investigation inspiratory muscle training will be applied in a randomized controlled fashion in 40 patients over a period of four weeks parallel to physical rehabilitation.

Interventions

DEVICEinspiratory muscle training

Sponsors

Krankenhaus Kloster Grafschaft
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COPD with FEV1/FVC \< 70 % * age \> 18 * stable disease * able to walk * carbon dioxide \>= 48 mmHg

Exclusion criteria

* ejection fraction of the heart \< 40 % * active psychiatric disease * bronchial hyperresponsiveness according to ATS criteria * pregnancy * renal insufficiency with a creatinine \< 2 mg/dl

Design outcomes

Primary

MeasureTime frame
Carbon dioxide level
inspiratory muscle strength
inspiratory muscle endurance
walking distance with dyspnea score

Countries

Germany

Contacts

Primary ContactDominic Dellweg, M.D.
d.dellweg@fkkg.de+49 2972 791

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026